Pre-cessation patch doubles quit success rate: Researchers call for labeli... ( DURHAM N.C. -- Using a nicotine patc...)

Pre-cessation patch doubles quit success rate: Researchers call for labeling changes

Date:7/9/2009

DURHAM, N.C. -- Using a nicotine patch before quitting smoking can double success rates, according to Duke University Medical Center researchers. They say their latest data suggest changes should be made to nicotine patch labeling.

"Right now, the nicotine patch is only recommended for use after the quit date," explains Jed Rose, director of the Duke Center for Nicotine and Smoking Research and lead author of the paper that is published online in the current issue of the journal Nicotine and Tobacco Research.

The current labeling resulted from concerns that using a patch while smoking could lead to nicotine overdose. However, a literature review found concurrent use of a nicotine patch and cigarette smoking appears to be safe.

"People who use the patch before quitting are likely to spontaneously reduce the number of cigarettes they smoke because the patch satisfies their need for nicotine and makes the act of smoking less enjoyable," he says. It also decreases withdrawal symptoms.

"Yet people are afraid to try a pre-cessation patch because the current labeling recommends users not smoke while on treatment," Rose says. "That's why our study is so important. It reinforces the findings of previous studies, which show the value of pre-cessation patch therapy, and demonstrates that using a pre-cessation nicotine patch can make a significant difference in a person's ability to quit."

Nearly 25 percent of the population continues to smoke despite the known health risks, according to previously published research. And, up to 90 percent of smokers who receive nicotine replacement therapy relapse within one year.

In an effort to find a successful smoking cessation method, Rose and his colleagues randomized 400 people who smoked an average of slightly more than one pack of cigarettes per day. They were put in four groups who either used a nicotine or placebo patch for two weeks prior to quitting smoking. They
'/>"/>

Contact: Debbe Geiger
Debbe.Geiger@duke.com
919-660-9461
Duke University Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. No Need for All-Day Patch to Treat Lazy Eye
2. No need for children with lazy eye to wear patches all day
3. Iomai Patch-Based Vaccine Cut Rate of Travelers Diarrhea by 75 Percent in Phase 2 Field Study
4. Long-term 12-month safety data on ADHD patch DAYTRANA
5. ActiPatch(TM) Granted Market Clearance by the Food & Drug Administration in the Kingdom of Jordan
6. Studies of 20,000 smokers show quit rates double with counseling and free nicotine patches
7. FDA Renews Warnings on Pain-Relief Patch
8. FDA Warns Clot Risk Higher in Birth Control Patch Than Pill
9. Ringing endorsement: Women prefer contraceptive ring over patch
10. Iomai Study Shows Self-Applied Travelers Diarrhea Vaccine Patch Comparable to Clinician-Applied Vaccine Patch
11. PriCara(TM) Recalls 25 mcg/hr DURAGESIC(R) (fentanyl transdermal system) CII Pain Patches

Post Your Comments:

(Date:12/1/2009)... CAEAR Foundation Changes Name to HealthHIV , ...e CAEAR Foundation, one of the largest national HI...o HealthHIV and launching a new website. The annou... of a campaign to promote the organization’s... , , , ,“HealthHIV clearly, quickly and eas...

(Date:12/1/2009)...EANS, Dec. 1 The Americ...l High School Student Symposium at the New Orleans...T. The symposium, which encourages an interest in ...esearch, is held in conjunction with the Society,s...e the opportunity to explore research on sickle ce...

(Date:12/1/2009)... Dec. 1 With employee be...ber of employers are providing self-service decisi...season, according to a new survey by Watson Wyatt,...mployers who offer these tools believe they lead e...,, According to the survey, 45 percent of compa...

(Date:12/1/2009)...NS, Dec. 1 The American...professional association of blood specialists, exp...nual Meeting from December 5-8, 2009, at the Ernes...The meeting will showcase the latest research and ...leasure to host ASH,s 51st annual meeting, where w...

(Date:12/1/2009)..., Dec. 1 The government of Mexico ...enter for biomedical and nanomedical research, cal...research and development will be integrated with t...op Spanish speaking university in the world. The ...in 2010, has been designed by the internationally-...

Breaking Medicine News(10 mins):Health News:National HIV Non-Profit Announces New Name 2 Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 2 Health News:ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum 3 Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 2 Health News:Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds 3 Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 2 Health News:51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care 3 Health News:Mexico City to Build World-Class Hub for Medical Research 2

[0] National HIV Non-Profit Announces New Name [0] ASH to Encourage High School Students to Pursue Biomedical Research Through Special Symposium and Science Curriculum [0] Employers Plan to Increase Use of Self-Service Decision-Making Technology For Open Enrollment, Watson Wyatt Survey Finds [0] 51st Annual Meeting of the American Society of Hematology Will Highlight Research and Policy Changes Affecting Medical Practice and Patient Care [0] Mexico City to Build World-Class Hub for Medical Research

...of its pioneering stem cell program, the Universit...4.9 million grant from the California Institute fo...uction of a regenerative medicine building on its ...F receiving a portion of funding from CIRM. The re...

...ama at Birmingham (UAB) this month became the firs...adiation therapy. The new technique can turn a 20-...on for selected patients. , Additionally, the new...g to doctors at the UAB Comprehensive Cancer Cente...

...PHILADELPHIA, May 7 Kappa Alpha Psi Fraternity, I...oing partnership with the St.,Jude Children,s Rese...n,children. The celebration will be held at the St...sponsibility of sponsoring events at the local lev...

...CNO ),today reported results for the first quarter...with an increase of 10.7% over,the same period las...cluded,an 11% increase at Bankers Life and a 22% i...21%, but specified disease,products, CIG,s highest...

..., study finds, , , WEDNESDAY, May 7 (Healt...uring pregnancy face an increased risk of complica... meet the criteria for gestational diabetes. , In...such as having a large birth weight baby or needin...

....,(OTC Bullentin Board: DSCI), provider of advance...ts first quarter 2008 results before market on,Thu...rence call that same,day to discuss the results at...may also access this call via the Internet,at:, ...

UCSF receives funding for building from California stem cell agency UAB first in US to offer speedier precise cancer radiotherapy Kappa Alpha Psi Fraternity Celebrates St. Jude Partnership Conseco Reports First Quarter Results High Blood Sugar Tied to Pregnancy Complications Derma Sciences Announces Date of Its First Quarter 2008 Earnings Release and Conference Call on May 15, 2008

(Date:12/1/2009)... 1 RoundTable Healthcare Partners,... exclusively on the health-care industry, announce...ement to sell one of its portfolio companies, Asce...oration ("Stryker"), one of the world,s leading me...sh. Prior to closing, Ascent will distribute $35 ...

(Date:12/1/2009)...ercent radiation reduction in cardiac CT scans ,...James Earls, a radiologist from Fairfax Radiologic...resent the findings of a study that shows a 90 per...tients received from CT scans compared to scans pe...ent the study to the annual meeting of the Radiolo...

(Date:12/1/2009)... 1 CeloNova BioSciences, Inc., a p...l devices and of specialty implants, today announc...mas A. Gordy, will give an opening address for the...cular Interventions Conference in Tel Aviv, Israel...ehind and focus the rich intellectual resources of...

[0] RoundTable Healthcare Partners Announces Sale of Ascent Healthcare Solutions to Stryker Corporation [0] Radiation Reduction in Heart CT Scans Reported in Study [0] CeloNova BioSciences CEO Urges More Heart, More Passion, More Honesty, and All Urgency in Developing Medical Devices

...)--Apr 19, 2007 - Abraxis BioScience,Inc. (NASDAQ...mpany, announced results from two pre-clinical stu...ein acidic and rich in,cysteine) expression in can...M)) tumor-targeting technology at the 98th,America...eting held,April 14-18, 2007 in Los Angeles., "Bot...

...INESS WIRE)--Apr 19, 2007 - Amgen,(NASDAQ: AMGN) t...andomized, double-blind, placebo-controlled, multi...fa) in 600 previously untreated,patients with exte...g platinum-containing chemotherapy. The study demo...n risk of death (overall,survival Aranesp compared...

Other Medicine Technology:Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 2 Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 3 Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 4 Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway 5 Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2 Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3 Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4 Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5 Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6 Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7

Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer

MOST Options Systems - Straight Smooth

The Natural-Hip Family - Revision/Trauma Nonporous CoCr

MARATHON Cross Linked Polyethylene Acetabular Liner

Ringloc Acetabular Liners

Medicine Products:

MOST Options Systems - Straight Smooth The Natural-Hip Family - Revision/Trauma Nonporous CoCr MARATHON Cross Linked Polyethylene Acetabular Liner Ringloc Acetabular Liners

Pre-cessation patch doubles quit success rate: Researchers call for labeli...( DURHAM N.C. -- Using a nicotine patc...),Health